These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35265567)

  • 1. Case Report: A Case of β-Ureidopropionase Deficiency Complicated With MELAS Syndrome Caused by
    Shu J; Zhi X; Chen J; Lei M; Zheng J; Sheng W; Zhang C; Li D; Cai C
    Front Pediatr; 2022; 10():838341. PubMed ID: 35265567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR-based urinalysis for rapid diagnosis of β-ureidopropionase deficiency in a patient with Dravet syndrome.
    Lam CW; Law CY; Leung KF; Lai CK; Pak-lam Chen S; Chan B; Chan KY; Yuen YP; Mak CM; Yan-wo Chan A
    Clin Chim Acta; 2015 Feb; 440():201-4. PubMed ID: 25445412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Korean Case of β-Ureidopropionase Deficiency Presenting with Intractable Seizure, Global Developmental Delay, and Microcephaly.
    Lee JH; van Kuilenburg AB; Abeling NG; Vasta V; Hahn SH
    JIMD Rep; 2015; 19():117-21. PubMed ID: 25638458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of the UPB1 gene in two new Chinese families with β-ureidopropionase deficiency and the carrier frequency of the mutation c.977G>A in Northern China.
    Shu J; Lv X; Jiang S; Zhang Y; Zhang C; Meng Y; Situ A; Xu H; Song L
    Childs Nerv Syst; 2014 Dec; 30(12):2109-14. PubMed ID: 25236466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between beta-ureidopropionase deficiency due to UPB1 variants and human phenotypes is uncertain.
    Righetti S; Allcock RJN; Yaplito-Lee J; Adams L; Ellaway C; Jones KJ; Selvanathan A; Fletcher J; Pitt J; van Kuilenburg ABP; Delatycki MB; Laing NG; Kirk EP
    Mol Genet Metab; 2022; 137(1-2):62-67. PubMed ID: 35926322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Ureidopropionase deficiency due to novel and rare UPB1 mutations affecting pre-mRNA splicing and protein structural integrity and catalytic activity.
    Dobritzsch D; Meijer J; Meinsma R; Maurer D; Monavari AA; Gummesson A; Reims A; Cayuela JA; Kuklina N; Benoist JF; Perrin L; Assmann B; Hoffmann GF; Bierau J; Kaindl AM; van Kuilenburg ABP
    Mol Genet Metab; 2022 Jul; 136(3):177-185. PubMed ID: 35151535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome with mitochondrial DNA 3243A>G mutation masquerading as autoimmune encephalitis: A case report.
    Wang JW; Yuan XB; Chen HF
    World J Clin Cases; 2023 May; 11(14):3275-3281. PubMed ID: 37274040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic analysis of 7 Chinese patients with β-ureidopropionase deficiency.
    Fang Y; Cai C; Wang C; Sun B; Zhang X; Fan W; Hu W; Meng Y; Lin S; Zhang C; Zhang Y; Shu J
    Medicine (Baltimore); 2019 Jan; 98(1):e14021. PubMed ID: 30608453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Japanese case of β-ureidopropionase deficiency with dysmorphic features.
    Akiyama T; Shibata T; Yoshinaga H; Kuhara T; Nakajima Y; Kato T; Maeda Y; Ohse M; Oka M; Kageyama M; Kobayashi K
    Brain Dev; 2017 Jan; 39(1):58-61. PubMed ID: 27553092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities.
    van Kuilenburg AB; Meinsma R; Beke E; Assmann B; Ribes A; Lorente I; Busch R; Mayatepek E; Abeling NG; van Cruchten A; Stroomer AE; van Lenthe H; Zoetekouw L; Kulik W; Hoffmann GF; Voit T; Wevers RA; Rutsch F; van Gennip AH
    Hum Mol Genet; 2004 Nov; 13(22):2793-801. PubMed ID: 15385443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Novel Variant in
    Xu M; Kopajtich R; Elstner M; Wang Z; Liu Z; Wang J; Prokisch H; Fang F
    Front Genet; 2021; 12():638749. PubMed ID: 34054915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, biochemical and molecular analysis of 13 Japanese patients with β-ureidopropionase deficiency demonstrates high prevalence of the c.977G > A (p.R326Q) mutation [corrected].
    Nakajima Y; Meijer J; Dobritzsch D; Ito T; Meinsma R; Abeling NG; Roelofsen J; Zoetekouw L; Watanabe Y; Tashiro K; Lee T; Takeshima Y; Mitsubuchi H; Yoneyama A; Ohta K; Eto K; Saito K; Kuhara T; van Kuilenburg AB
    J Inherit Metab Dis; 2014 Sep; 37(5):801-12. PubMed ID: 24526388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Publisher's note. Identification of a novel synonymous mutation in the human β-ureidopropionase gene UPB1 affecting pre-mRNA splicing.
    Meijer J; Nakajima Y; Zhang C; Meinsma R; Ito T; Van Kuilenburg AB
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):639-45. PubMed ID: 24940676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the
    Endres D; Süß P; Maier SJ; Friedel E; Nickel K; Ziegler C; Fiebich BL; Glocker FX; Stock F; Egger K; Lange T; Dacko M; Venhoff N; Erny D; Doostkam S; Komlosi K; Domschke K; Tebartz van Elst L
    Front Immunol; 2019; 10():412. PubMed ID: 30949164
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a novel synonymous mutation in the human β -Ureidopropionase Gene UPB1 affecting pre-mRNA splicing.
    Meijer J; Nakajima Y; Zhang C; Meinsma R; Ito T; Van Kuilenburg AB
    Nucleosides Nucleotides Nucleic Acids; 2013; 32(12):639-45. PubMed ID: 24328561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
    El-Hattab AW; Adesina AM; Jones J; Scaglia F
    Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation.
    Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Rodenburg RJ; de Laat P; Smeitink JAM; Janssen MCH; Louw R
    Metabolomics; 2021 Jan; 17(1):10. PubMed ID: 33438095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Intestinal Pseudo-Obstruction Drive Recurrent Stroke-Like Episodes in Late-Onset MELAS Syndrome? A Case Report and Review of the Literature.
    Gagliardi D; Mauri E; Magri F; Velardo D; Meneri M; Abati E; Brusa R; Faravelli I; Piga D; Ronchi D; Triulzi F; Peverelli L; Sciacco M; Bresolin N; Comi GP; Corti S; Govoni A
    Front Neurol; 2019; 10():38. PubMed ID: 30766507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset MELAS syndrome in a 46-year-old man with initial symptom of chest tightness: a case report.
    Wang A; Zhao J; Zhao Y; Yan Y
    Eur Heart J Case Rep; 2023 Sep; 7(9):ytad441. PubMed ID: 37767231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chorea-ballism as a dominant clinical manifestation in heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation in mitochondrial genome: a case report.
    Lahiri D; Sawale VM; Banerjee S; Dubey S; Roy BK; Das SK
    J Med Case Rep; 2019 Mar; 13(1):63. PubMed ID: 30837005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.